263 Pleiotropic effects of IL-7 in prostate cancer patients receiving Sipuleucel-T vaccination

263 Pleiotropic effects of IL-7 in prostate cancer patients receiving Sipuleucel-T vaccination

Bibliographic Details
Main Authors:	Chihiro Morishima, Lawrence Fong, Holden Maecker, Leonard D’Amico, Steven Fling, Martin Cheever, Nirasha Ramchurren, Sean Bendall, Caroline Duault, Mina Pichavant, Bita Sahaf
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2020-11-01
Series:	Journal for ImmunoTherapy of Cancer

Similar Items

Effects of a prostaglandin precursor, gamma-linolenic acid (GLA), on malignant cells in vitro and in vivo.
by: Ramchurren, Nirasha.
Published: (2011)

Immune Response to Sipuleucel-T in Prostate Cancer
by: David I. Quinn, et al.
Published: (2012-04-01)

Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
by: Rhonda L. Bitting, et al.
Published: (2011-01-01)

Management Options in Advanced Prostate Cancer: What is the Role for Sipuleucel-T?
by: Rhonda L. Bitting, et al.
Published: (2011-10-01)

Sipuleucel-T in patients with metastatic castration-resistant prostate cancer: an insight for oncologists
by: Jorge A. Garcia
Published: (2011-03-01)

The Lack of Predictors for Rapid Progression in Prostate Cancer Patients Receiving Sipuleucel-T
by: John Araujo, et al.
Published: (2013-05-01)

Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer
by: Katsunobu Hagihara, et al.
Published: (2019-01-01)

What is the role of sipuleucel-T in the treatment of patients with advanced prostate cancer? An update on the evidence
by: Rachel Hu, et al.
Published: (2016-08-01)

Moving on From Sipuleucel-T: New Dendritic Cell Vaccine Strategies for Prostate Cancer
by: Sarah I. M. Sutherland, et al.
Published: (2021-03-01)

Sipuleucel-T and Androgen Receptor-Directed Therapy for Castration-Resistant Prostate Cancer: A Meta-Analysis
by: Renliang Yi, et al.
Published: (2016-01-01)

26,3%
by: Mercedes Ruiz Paz
Published: (2004-09-01)

RECL 263 -
Published: (2011)

Sipuleucel‐T associated inflammatory cardiomyopathy: a case report and observations from a large pharmacovigilance database
by: Melissa Y.Y. Moey, et al.
Published: (2021-08-01)

Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
by: Graça M. Dores, et al.
Published: (2019-12-01)

Sipuleucel-T: Autologous Cellular Immunotherapy for Men with Asymptomatic or Minimally Symptomatic Metastatic Castrate Resistant Prostate Cancer
by: Robert B. Sims
Published: (2011-01-01)

Expression and characterization of cellulases from Daldinia caldariorum 263 (D263)
by: Sheng-ChihYang, et al.
Published: (2012)

Sipuleucel-T for therapy of asymptomatic or minimally symptomatic, castrate-refractory prostate cancer: an update and perspective among other treatments
by: Gupta SG, et al.
Published: (2011-06-01)

Editorial 26.3
by: Ailton Vitor Guimarães
Published: (2018-02-01)

Pre-existing immune status associated with response to combination of sipuleucel-T and ipilimumab in patients with metastatic castration-resistant prostate cancer
by: Padmanee Sharma, et al.
Published: (2021-05-01)

Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T
by: Jeffrey Huang, et al.
Published: (2021-08-01)

Phase I clinical trial of sipuleucel-T combined with escalating doses of ipilimumab in progressive metastatic castrate-resistant prostate cancer
by: Scholz M, et al.
Published: (2017-03-01)

Pré-textuais 26.3
by: Ailton Vitor Guimarães
Published: (2018-02-01)

On Pečarić-Rajić-Dragomir-Type Inequalities in Normed Linear Spaces
by: Chen Chur-Jen, et al.
Published: (2009-01-01)

On Pečarić-Rajić-Dragomir-Type Inequalities in Normed Linear Spaces
by: Wing-Sum Cheung, et al.
Published: (2009-01-01)

A Novel Loss-of-Function Variant in Transmembrane Protein 263 (TMEM263) of Autosomal Dwarfism in Chicken
by: Zhou Wu, et al.
Published: (2018-06-01)

Immune profiling of COVID-19: preliminary findings and implications for the pandemic
by: Holden T Maecker
Published: (2021-05-01)

Human CD81 directly enhances T<sub>h</sub>1 and T<sub>h</sub>2 cell activation, but preferentially induces proliferation of T<sub>h</sub>2 cells upon long-term stimulation
by: Maecker Holden T
Published: (2003-02-01)

Immunotherapy with Sipuleucel-T (APC8015) in patients with metastatic castration-refractory prostate cancer (mCRPC): a systematic review and meta-analysis
by: Tobias Engel Ayer Botrel, et al.
Published: (2012-12-01)

RECL 263 - 4-Jun-84
Published: (2011)

RECL 263 - 17-Aug-84
Published: (2011)

RECL 263 - 3-Aug-85
Published: (2011)

RECL 263 - 26-Jul-86
Published: (2011)

RECL 263 - 1-Sep-90
Published: (2011)

RECL 263 - 2-Aug-94
Published: (2011)

RECL 263 - 26-Jul-98
Published: (2011)

RECL 263 - 13-Aug-89
Published: (2011)

Motion estimator design for H.263
by: Lin, Gong-Sheng, et al.
Published: (1997)

Merkel cell polyomavirus-specific immune responses in patients with Merkel cell carcinoma receiving anti-PD-1 therapy
by: Natalie J. Miller, et al.
Published: (2018-11-01)

Pleiotropic effects of statins
by: Narasaraju Kavalipati, et al.
Published: (2015-01-01)

Pleiotropic effects of incretins
by: Vishal Gupta
Published: (2012-01-01)